α-SMA+ cell depletion totally destabilized tumor stroma resulting in immune surveillance suppression associated with a decreased Teff/Treg ratio and a significant elevation in Ctla4 expression and demonstrated no therapeutic advantage even in combination with gemcitabine. The gene discussed is ACTA1; the disease is neoplasm.